We would like to create awareness of rare diseases and the necessity of collaborating to improve the quality of life of those suffering them. We thank RareDiseaseDay® for spreading the word! #ShowYourRare
Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by the US Food and Drug Administration (FDA) on 20 October 2014.
Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.